News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Calgenex Corporation Introduces New Topical Psoriasis Treatment


9/27/2006 12:35:16 PM

TAMPA, Fla.--(BUSINESS WIRE)--Calgenex Corporation today announced the introduction of Dermalleve, a new over-the-counter (OTC) topical drug treatment for psoriasis, eczema, and seborrheic dermatitis. Dermalleve combines maximum-strength anti-pruritic medicine with natural skin conditioners and emollients to stop the itching, reduce inflammation, and support the body’s healing process.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES